Navigation Links
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
Date:3/24/2008

gap of less than or equal to 35 days.

Viral load reduction in chronic hepatitis B patients treated with BARACLUDE(R) (entecavir) in nucleoside-naive and lamivudine-refractory studies was also evaluated.

Data Results

Results from these studies prior to this year five analysis were previously announced on April 14, 2007.

Nucleoside-naive data

-- The incidence of BARACLUDE resistance in patients in

nucleoside-naive studies over time is low, with a cumulative

probability of genotypic BARACLUDE resistance of 1.2 percent

through five years.

-- No nucleoside-naive patient developed resistance (n=108) in year

five.

-- 93 percent of the nucleoside-naive patients taking BARACLUDE were

able to achieve and maintain an undetectable viral load

(HBV DNA <300 copies/mL) through year five (n=108).

Lamivudine-refractory data

-- The results in lamivudine-refractory patients in years one through

five were consistent with the finding that the pre-existence of

lamivudine-resistant substitutions resulted in an increase in the

emergence of BARACLUDE resistance, with a cumulative probability of

genotypic resistance of 51 percent through five years.

-- In year five, 43 percent of lamivudine-refractory patients had

virologic breakthrough with BARACLUDE resistance (n=33).

-- During this resistance monitoring program, 68 of the 187

lamivudine-refractory patients achieved undetectable viral load

(<300 copies/mL) and of these, one patient developed virologic

breakthrough due to BARACLUDE resistance.

Indication and Important Safety Information About BARACLUDE(R) (entecavir) 0.5 mg/1 mg Tablets

BARACLUDE(R) (entecavir) is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults where the virus is multiplying and
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
2. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
3. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
4. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
5. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
6. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
7. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
10. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
11. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... , Aug. 21, 2014  IBM (NYSE: IBM ... ( DESY ), a leading national research center in ... and storage of massive volumes of x-ray data. The ... on IBM software defined technology can handle more than ... and help scientists worldwide gain faster insights into the ...
(Date:8/21/2014)... , Aug. 21, 2014  Seventy-one percent of Americans believe ... is a serious public health and safety issue in ... a survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse ... with this very serious health situation facing our country," ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... , , , ... the leader in the development of devices for the percutaneous ... group of patients with the MitraClip((R)) system at the Elisabethinen ... device commercially available in the European Union which provides a ...
... HERNDON, Va., Sept. 8 BHR Pharma, ... global, Phase 3, multi-center pivotal trial ( www.synapse-trial.com ) ... product as a neuroprotective agent for treating severe traumatic brain injury ... will enroll approximately 1,200 patients with severe (Glasgow Coma Scale scores ...
Cached Medicine Technology:MitraClip(R) Therapy Introduced in Austria 2MitraClip(R) Therapy Introduced in Austria 3BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 2
(Date:8/21/2014)... News) -- Being born at a low birth weight puts ... new study suggests. The findings may partly explain high ... high prevalence of low birth weight, the researchers added. ... those with a low birth weight were 13 percent more ... normal birth weight. The risk of diabetes was 40 percent ...
(Date:8/21/2014)... 21, 2014 The W. Montague ... and a national voice in the elimination of ... disparities during the 112th National Medical Association’s (NMA) ... included: , John Ruffin, Ph.D, former Director of ... Disparities, whose life-long career and innovations have had ...
(Date:8/21/2014)... WA (PRWEB) August 21, 2014 ... Mulanax at Eastlake Chiropractic and Massage Center ... the Center’s growing team. Rina Lang, LMP and ... a wide range of massage techniques, and have developed ... settings. This is particularly important in a clinical ...
(Date:8/21/2014)... SAN FRANCISCO Aug. 21, 2014 Researchers in ... for congenital cataracts can quickly and accurately diagnose a ... to a study published online today in ... of Ophthalmology. Using a single test, doctors were ... based on their mutations reducing the time and money ...
(Date:8/21/2014)... August 21, 2014 The world wound ... billion in 2014 and reach USD 18.3 billion by ... period. The drivers of such growth include governments’ contribution ... and diabetic population, and surging ageing population. However, the ... wound care products. Region-wise, North America leads the global ...
Breaking Medicine News(10 mins):Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 3Health News:New DNA test for diagnosing diseases linked to childhood blindness 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3
... Home Workers in PA, MI, IL, FL, OH, MD, WI, WA Join Forces ... Private Equity ... Buyout, WASHINGTON, Oct. 3 ... workers union today,is launching a multi-state grassroots campaign calling on global buyout,giant the ...
... quit, researchers say , WEDNESDAY, Oct. 3 (HealthDay News) ... linked to nicotine dependence and to the anxiety and ... Scripps Research Institute in La Jolla, Calif., said the ... smokers kick the habit. , In rats, chronic nicotine ...
... 3 The following is a,statement of William ... President Bush today let down America,s children and ... legislation that would,increase the federal cigarette tax by ... Children,s Health Insurance Program (SCHIP). The President has ...
... Conn., Oct. 3 ,Unilens Vision Inc. (OTC Bulletin Board: ... that Eschenbach Optik has been named,the exclusive worldwide distributor ... Inc. will serve as the exclusive distributor,for North and ... be the,exclusive distributor in the rest of the world. ...
... and Revitalization, ORLANDO, Fla., Oct. 3 ... PRZ ), one of the nation,s leading providers,of ... issued,the following corporate update detailing recent developments that ... refined long term,growth strategy. Specifically, Lubinsky stated: ...
... Education Campaign Urges Enrollment, LOS ANGELES, Oct. 3 ... of clinical trials are being conducted to seek a,treatment, ... potentially fatal,autoimmune disease that affects more than 1.5 million ... key question that clinical trials answer is, "Will this ...
Cached Medicine News:Health News:SEIU Launches Multi-State Grassroots Campaign Calling on the Carlyle Group to Put Care Above Profits in Buyout of Nation's Largest Nursing Home Chain 2Health News:Rat Study Gets at Root of Nicotine Addiction 2Health News:President's Veto of Bill to Increase Cigarette Tax, Fund SCHIP Benefits Big Tobacco at Expense of America's Kids 2Health News:Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens 2Health News:Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens 3Health News:PainCare Reports on Key Corporate Developments 2Health News:PainCare Reports on Key Corporate Developments 3Health News:PainCare Reports on Key Corporate Developments 4Health News:PainCare Reports on Key Corporate Developments 5Health News:Clinical Trials for Lupus Underway After Decades of Drought 2
... Reichert TONO-PEN AVIA tonometer is an ... readings that correlate strongly with Goldmann ... ergonomic design and advanced electronic measurement ... fast and accurate IOP measurements with ...
... Delivery System is a ... to assemble brachytherapy seeds, ... into seed trains of ... variable seed to seed ...
... from innovative research in materials and technologies ... the aerospace and automotive industry, the high- ... footwear and textile industry. , ,This know-how ... Carrera sunglasses collection to create unique and ...
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Medicine Products: